Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Turkey steps up crackdown on humanitarian aid groups
04/27/2017. Turkish authorities have detained 15 staff of a US NGO working on Syria relief operations – the latest in a series of moves restricting humanitarian aid groups in the country.
INTERVIEW: UN humanitarian chief Stephen O’Brien
09/21/2015. “At the end of the day, every life saved is an achievement in itself.”
The return of an old scourge : starvation
03/31/2017. Famine was supposed to be a thing of the past. True, 75 million people had died from starvation in the 20th century, but we had learned from these tragedies, how to predict them and how to address them.
